Why was October jobs report canceled?
How did Nvidia’s earnings affect AI stocks?
What drives Saudi Arabia’s investment in US AI?
Why is Meta winning its FTC antitrust case?
How are Trump’s tariffs impacting US trade deficit?
What caused Ford’s recent Bronco vehicle recall?
Why is Target’s sales outlook weakening?
Merck's Winrevair Success Extends Beyond Pulmonary Hypertension, Showing Promise In Complex Heart Condition
benzinga.com/news/health-care/25/11/48931416/mercks-winrevair-success-extends-beyond-pulmonary-hypertension-showing-promise-in-complex-heart-
Merck & Co. Inc. (NYSE:MRK) on Tuesday released topline results from the Phase 2 CADENCE study of Winrevair (sotatercept-csrk) in adults for combined post- and precapillary pulmonary hypertension (CpcPH) due to heart failure with preserved ejection fraction (HFpEF).
• MRK is among…
This story appeared on benzinga.com, 2025-11-18 17:42:18.